Inventor
SIMONS MICHAEL
US21 patents
⚠️ This page may combine multiple inventors who share the name “SIMONS MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BETH ISRAEL HOSPITAL
7 patentsUS6815187B1Nov 9, 2004
Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway
BETH ISRAEL HOSPITAL2 citations58
US6667388B2Dec 23, 2003
Peptide inhibitor of MMP activity and angiogenesis
BETH ISRAEL HOSPITAL5 citations56
US7345021B1Mar 18, 2008
Method for PR-39 peptide regulated stimulation of angiogenesis
BETH ISRAEL HOSPITAL3 citations54
US7029668B2Apr 18, 2006
Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
BETH ISRAEL HOSPITAL5 citations54
US7202212B2Apr 10, 2007
Method for PR-39 peptide mediated selective inhibition of lκBα degradation
BETH ISRAEL HOSPITAL1 citations47
US6852515B1Feb 8, 2005
Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core
BETH ISRAEL HOSPITAL1 citations43
US7169604B1Jan 30, 2007
Method for PR-39 peptide mediated selective inhibition of IκBα degradation
BETH ISRAEL HOSPITAL0 citations36
UNIV YALE
3 patentsUS11326167B2May 10, 2022
Methods and compositions for treating atherosclerosis
UNIV YALE2 citations72
US9782522B2Oct 10, 2017
Compositions and methods for treating and preventing neointimal stenosis
UNIV YALE0 citations48
US10450570B2Oct 22, 2019
Compositions and methods for controlling vasculature
UNIV YALE0 citations42